TerrAscend to Acquire Pennsylvania Dispensary Chain for $63 Million – THCnet

North American cannabis firm TerrAscend will double its dispensary footprint in Pennsylvania via the acquisition of KCR Holdings.

The $63 million cash-and-stock transaction includes $36 million in stock, $20.25 million in cash, and a $6.75 million note. It is expected to close in the second quarter of 2021.

TerrAscend already owns 10% of KCR, — which operates the Keystone Canna Remedies chain of dispensaries in Bethlehem, Allentown, and Stroudsburg — meaning the $63 million purchase price implies an enterprise value of $70 million.

“This expanded retail footprint further solidifies our position as the leading branded cultivator and manufacturer in Pennsylvania,” TerrAscend executive chairman Jason Wild said via a news release.

Currently, Pennsylvania only permits the sale of medical marijuana. However, neighboring New Jersey and New York recently legalized adult-use cannabis, and many industry stakeholders expect Pennsylvania to follow suit.

The acquisition comes just one month after TerrAscend terminated CEO Jason Ackerman. The company plans to reach $290 million in net sales this year.

In addition to Pennsylvania, TerrAscend has operations in New Jersey and California. It also participates in the medical and adult-use cannabis markets in Canada.

Additional information is available in the release below.

TerrAscend Doubles Dispensary Footprint in

Read More Here…

Share on facebook
Share on twitter
Share on reddit
Share on pinterest
Share on email

Bud Digest

Leave a Comment

Your email address will not be published. Required fields are marked *